PTPI - Petros Pharmaceuticals, Inc.
0.0082
0.000 1.220%
Share volume: 69,747
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.01
0.00
0.01%
View ratios
| Fiscal Date | 09-30-2025 | |
|---|---|---|
| Fiscal Quarter | Q3 2025 | |
| Report Date | 11-13-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 990.737 K | |
| Selling general and admin | 990.737 K | |
| Research and development | 0.000 | |
| Total expenses | 990.737 K | |
| Operating income | -990.737 K | |
| Ebit | -989.737 K | |
| Pretax income | -922.723 K | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -922.723 K | |